Oligonucleotide Therapeutics as a New Class of Drugs for Malignant Brain Tumors: Targeting mRNAs, Regulatory RNAs, Mutations, Combinations, and Beyond

Autor: Krichevsky, Anna M., Uhlmann, Erik J.
Zdroj: In Neurotherapeutics April 2019 16(2):319-347
Databáze: ScienceDirect